LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...
Narayana Health sets its first-of-its-kind robotic cardiac centre of excellence: Our Bureau, Bengaluru Wednesday, September 25, 2024, 17:40 Hrs [IST] Narayana Health, unveiled fir ...
Chugai receives Japanese additional indication approval for Evrysdi in pre-symptomatic SMA and additional dosage for infants under 2 months of age: Tokyo Wednesday, September 25, ...
Emmes, part of Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), has been selected by the National Institutes of Health’s (NIH) NIDA [National Institute of ...
Takeda receives Japanese nod to manufacture and market Fruzaqla to treat unresectable advanced or recurrent colorectal cancer: Osaka, Japan Wednesday, September 25, 2024, 16:30 Hr ...
Cloudnine Hospital to enhance skills to ensure zero errors for doctors: Our Bureau, Bengaluru Wednesday, September 25, 2024, 16:15 Hrs [IST] Cloudnine, India’s premier birthing ...
NIH awards $27 million to establish new network of genomics-enabled learning health systems: Bethesda, Maryland Wednesday, September 25, 2024, 16:00 Hrs [IST] The National Institu ...
World Pharmacist Day 2024 reinstates access to essential medicines and disease prevention: Our Bureau, Bengaluru Wednesday, September 25, 2024, 15:50 Hrs [IST] World Pharmacists D ...
Aileron Therapeutics completes patient enrollment in Cohort 2 of phase 1b trial of LTI-03 in idiopathic pulmonary fibrosis: Austin, Texas Wednesday, September 25, 2024, 15:00 Hrs ...
Cactus and Gubbi Labs report identifies key opportunities for innovation, international collaboration, & investment in biopharma: Our Bureau, Bengaluru Wednesday, September 25, 20 ...